NEW YORK (GenomeWeb News) – The National Institutes of Health on Friday issued requests for applications for two trans-NIH funding programs for small businesses focused on bioscience and biomedicine, including the Small Business Innovation Research grants and the Small Business Technology Transfer program.
The STTR grants will give either up to $100,000 (Phase I) for one year or $750,000 (Phase II) for up to two years.
The SBIR grants will provide either up to $100,000 (Phase I) for a period of up to six months or up to $750,000 (Phase II) for a period of no more than two years.
The STTR program is aimed at using federal funds to stimulate "a partnership of ideas and technologies between innovative small business concerns and non-profit institutions," and to assist small businesses and research communities in commercializing innovative technologies, according to NIH.
The SBIR program is focused on several goals, including: stimulating technological innovation in the private sector; strengthening the role of small business in meeting federal R&D needs; increasing commercial applications of federally-supported research; fostering participation by socially and economically disadvantaged and women-owned small business concerns; improving the return on investment from federally-funded research.